PJ
Peter John Jones
Current PSC Person with significant control at PHARMALYNX LTD
Notified on 30th Jun 2016
Peter John Jones
Reports & checks
Buy a company report
Run an identity check
Natures of control
- Ownership of shares 25 to 50 percent
- Voting rights 25 to 50 percent